Literature DB >> 12052600

Prognostic factors for the success of thermal balloon ablation in the treatment of menorrhagia.

M Y Bongers1, B W J Mol, H A M Brölmann.   

Abstract

OBJECTIVE: To identify predictive factors that will ensure successful menorrhagia treatment using hot fluid balloon endometrial ablation.
METHODS: This is a prospective study on patients referred for menorrhagia and treated with hot fluid thermal balloon ablation. Potential prognostic factors for assessing the success of treatment were recorded. Success was defined as patient satisfaction and no subsequent hysterectomy at 2-year follow-up.
RESULTS: A total of 130 women were included in the final analysis. The cumulative rate of patients undergoing a hysterectomy after 2 years was 12%. After 2 years, 81% of the remaining patients were satisfied with the results of the treatment. Predictive factors for adverse outcome were a retroverted uterus (hazard rate ratio 3.3, 95% confidence interval [CI] 1.2, 8.6), pretreatment endometrial thickness of at least 4 mm (hazard rate ratio 3.6, 95% CI 1.3, 11), and the duration of menstruation (hazard rate ratio 1.2, 95% CI 1.0, 1.3, per day in excess of 9 days). The risk of an adverse outcome declined steadily with increasing age (hazard rate ratio 0.86, 95% CI 0.77, 0.96 per year over 42 years of age). Uterine depth and dysmenorrhea were not predictive factors, which significantly affected outcome.
CONCLUSION: Young age, retroverted uterus, endometrial thickness of at least 4 mm, and prolonged duration of menstruation were associated with an increased risk of treatment failure. Uterine depth and dysmenorrhea had limited impact on the effectiveness of balloon ablation.

Entities:  

Mesh:

Year:  2002        PMID: 12052600     DOI: 10.1016/s0029-7844(02)02011-2

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  6 in total

1.  The retroverted uterus: ignored to date but core to prolapse.

Authors:  Bernard T Haylen
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2006-07-05

2.  Outpatient Thermachoice endometrial balloon ablation: long-term, prognostic and quality-of-life measures.

Authors:  Rajesh Varma; Hemi Soneja; Nadia Samuel; Eki Sangha; Thomas Justin Clark; Janesh K Gupta
Journal:  Gynecol Obstet Invest       Date:  2010-06-16       Impact factor: 2.031

3.  Endometrial ablation plus levonorgestrel releasing intrauterine system versus endometrial ablation alone in women with heavy menstrual bleeding: study protocol of a multicentre randomised controlled trial; MIRA2 trial.

Authors:  Tamara J Oderkerk; Pleun Beelen; Peggy M A J Geomini; Malou C Herman; Jaklien C Leemans; Ruben G Duijnhoven; Judith E Bosmans; Justine N Pannekoek; Thomas J Clark; Ben Willem J Mol; Marlies Y Bongers
Journal:  BMC Womens Health       Date:  2022-06-27       Impact factor: 2.742

4.  Prediction of treatment outcomes after global endometrial ablation.

Authors:  Sherif A El-Nashar; Matthew R Hopkins; Douglas J Creedon; Jennifer L St Sauver; Amy L Weaver; Michaela E McGree; William A Cliby; Abimbola O Famuyide
Journal:  Obstet Gynecol       Date:  2009-01       Impact factor: 7.661

5.  Characteristics of patients undergoing hysterectomy for failed endometrial ablation.

Authors:  Kristin A Riley; Matthew F Davies; Gerald J Harkins
Journal:  JSLS       Date:  2013 Oct-Dec       Impact factor: 2.172

Review 6.  Late-onset endometrial ablation failure.

Authors:  Morris Wortman
Journal:  Case Rep Womens Health       Date:  2017-07-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.